Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Rodenticides Market

ID: MRFR/Agri/8647-HCR
128 Pages
Snehal Singh
Last Updated: May 04, 2026

Rodenticides Market Size, Share, Industry Trend & Analysis Research Report By Type (Non-anticoagulant, Anticoagulant), By Rodent Type (Rat, Mouse, Hamsters, Chipmunk, Squirrels, Others), By Form (Pellet, Spray, Powder), By End User (Agricultural Fields, Warehouses, Others) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Rodenticides Market Infographic
Purchase Options
  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
    1. 1.1 EXECUTIVE SUMMARY | |
      1. 1.1.1 Market Overview | |
      2. 1.1.2 Key Findings | |
      3. 1.1.3 Market Segmentation | |
      4. 1.1.4 Competitive Landscape | |
      5. 1.1.5 Challenges and Opportunities | |
      6. 1.1.6 Future Outlook 2
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
    1. 2.1 MARKET INTRODUCTION | |
      1. 2.1.1 Definition | |
      2. 2.1.2 Scope of the study | | |
        1. 2.1.2.1 Research Objective | | |
        2. 2.1.2.2 Assumption | | |
        3. 2.1.2.3 Limitations |
    2. 2.2 RESEARCH METHODOLOGY | |
      1. 2.2.1 Overview | |
      2. 2.2.2 Data Mining | |
      3. 2.2.3 Secondary Research | |
      4. 2.2.4 Primary Research | | |
        1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
        2. 2.2.4.2 Breakdown of Primary Respondents | |
      5. 2.2.5 Forecasting Model | |
      6. 2.2.6 Market Size Estimation | | |
        1. 2.2.6.1 Bottom-Up Approach | | |
        2. 2.2.6.2 Top-Down Approach | |
      7. 2.2.7 Data Triangulation | |
      8. 2.2.8 Validation 3
  3. SECTION III: QUALITATIVE ANALYSIS |
    1. 3.1 MARKET DYNAMICS | |
      1. 3.1.1 Overview | |
      2. 3.1.2 Drivers | |
      3. 3.1.3 Restraints | |
      4. 3.1.4 Opportunities |
    2. 3.2 MARKET FACTOR ANALYSIS | |
      1. 3.2.1 Value chain Analysis | |
      2. 3.2.2 Porter's Five Forces Analysis | | |
        1. 3.2.2.1 Bargaining Power of Suppliers | | |
        2. 3.2.2.2 Bargaining Power of Buyers | | |
        3. 3.2.2.3 Threat of New Entrants | | |
        4. 3.2.2.4 Threat of Substitutes | | |
        5. 3.2.2.5 Intensity of Rivalry | |
      3. 3.2.3 COVID-19 Impact Analysis | | |
        1. 3.2.3.1 Market Impact Analysis | | |
        2. 3.2.3.2 Regional Impact | | |
        3. 3.2.3.3 Opportunity and Threat Analysis 4
  4. SECTION IV: QUANTITATIVE ANALYSIS |
    1. 4.1 Life Sciences, BY Type (USD Billion) | |
      1. 4.1.1 Non-anticoagulant | |
      2. 4.1.2 Anticoagulant |
    2. 4.2 Life Sciences, BY Rodent Type (USD Billion) | |
      1. 4.2.1 Rat | |
      2. 4.2.2 Mouse | |
      3. 4.2.3 Hamsters | |
      4. 4.2.4 Chipmunk | |
      5. 4.2.5 Squirrels | |
      6. 4.2.6 Others |
    3. 4.3 Life Sciences, BY Form (USD Billion) | |
      1. 4.3.1 Pellet | |
      2. 4.3.2 Spray | |
      3. 4.3.3 Powder |
    4. 4.4 Life Sciences, BY End User (USD Billion) | |
      1. 4.4.1 Agricultural Fields | |
      2. 4.4.2 Warehouses | |
      3. 4.4.3 Others |
    5. 4.5 Life Sciences, BY Region (USD Billion) | |
      1. 4.5.1 North America | | |
        1. 4.5.1.1 US | | |
        2. 4.5.1.2 Canada | |
      2. 4.5.2 Europe | | |
        1. 4.5.2.1 Germany | | |
        2. 4.5.2.2 UK | | |
        3. 4.5.2.3 France | | |
        4. 4.5.2.4 Russia | | |
        5. 4.5.2.5 Italy | | |
        6. 4.5.2.6 Spain | | |
        7. 4.5.2.7 Rest of Europe | |
      3. 4.5.3 APAC | | |
        1. 4.5.3.1 China | | |
        2. 4.5.3.2 India | | |
        3. 4.5.3.3 Japan | | |
        4. 4.5.3.4 South Korea | | |
        5. 4.5.3.5 Malaysia | | |
        6. 4.5.3.6 Thailand | | |
        7. 4.5.3.7 Indonesia | | |
        8. 4.5.3.8 Rest of APAC | |
      4. 4.5.4 South America | | |
        1. 4.5.4.1 Brazil | | |
        2. 4.5.4.2 Mexico | | |
        3. 4.5.4.3 Argentina | | |
        4. 4.5.4.4 Rest of South America | |
      5. 4.5.5 MEA | | |
        1. 4.5.5.1 GCC Countries | | |
        2. 4.5.5.2 South Africa | | |
        3. 4.5.5.3 Rest of MEA 5
  5. SECTION V: COMPETITIVE ANALYSIS |
    1. 5.1 Competitive Landscape | |
      1. 5.1.1 Overview | |
      2. 5.1.2 Competitive Analysis | |
      3. 5.1.3 Market share Analysis | |
      4. 5.1.4 Major Growth Strategy in the Life Sciences | |
      5. 5.1.5 Competitive Benchmarking | |
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Life Sciences | |
      7. 5.1.7 Key developments and growth strategies | | |
        1. 5.1.7.1 New Product Launch/Service Deployment | | |
        2. 5.1.7.2 Merger & Acquisitions | | |
        3. 5.1.7.3 Joint Ventures | |
      8. 5.1.8 Major Players Financial Matrix | | |
        1. 5.1.8.1 Sales and Operating Income | | |
        2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
    2. 5.2 Company Profiles | |
      1. 5.2.1 Bayer (DE) | | |
        1. 5.2.1.1 Financial Overview | | |
        2. 5.2.1.2 Products Offered | | |
        3. 5.2.1.3 Key Developments | | |
        4. 5.2.1.4 SWOT Analysis | | |
        5. 5.2.1.5 Key Strategies | |
      2. 5.2.2 BASF (DE) | | |
        1. 5.2.2.1 Financial Overview | | |
        2. 5.2.2.2 Products Offered | | |
        3. 5.2.2.3 Key Developments | | |
        4. 5.2.2.4 SWOT Analysis | | |
        5. 5.2.2.5 Key Strategies | |
      3. 5.2.3 Syngenta (CH) | | |
        1. 5.2.3.1 Financial Overview | | |
        2. 5.2.3.2 Products Offered | | |
        3. 5.2.3.3 Key Developments | | |
        4. 5.2.3.4 SWOT Analysis | | |
        5. 5.2.3.5 Key Strategies | |
      4. 5.2.4 Rentokil Initial (GB) | | |
        1. 5.2.4.1 Financial Overview | | |
        2. 5.2.4.2 Products Offered | | |
        3. 5.2.4.3 Key Developments | | |
        4. 5.2.4.4 SWOT Analysis | | |
        5. 5.2.4.5 Key Strategies | |
      5. 5.2.5 Neogen Corporation (US) | | |
        1. 5.2.5.1 Financial Overview | | |
        2. 5.2.5.2 Products Offered | | |
        3. 5.2.5.3 Key Developments | | |
        4. 5.2.5.4 SWOT Analysis | | |
        5. 5.2.5.5 Key Strategies | |
      6. 5.2.6 FMC Corporation (US) | | |
        1. 5.2.6.1 Financial Overview | | |
        2. 5.2.6.2 Products Offered | | |
        3. 5.2.6.3 Key Developments | | |
        4. 5.2.6.4 SWOT Analysis | | |
        5. 5.2.6.5 Key Strategies | |
      7. 5.2.7 Bell Laboratories (US) | | |
        1. 5.2.7.1 Financial Overview | | |
        2. 5.2.7.2 Products Offered | | |
        3. 5.2.7.3 Key Developments | | |
        4. 5.2.7.4 SWOT Analysis | | |
        5. 5.2.7.5 Key Strategies | |
      8. 5.2.8 Liphatech (US) | | |
        1. 5.2.8.1 Financial Overview | | |
        2. 5.2.8.2 Products Offered | | |
        3. 5.2.8.3 Key Developments | | |
        4. 5.2.8.4 SWOT Analysis | | |
        5. 5.2.8.5 Key Strategies |
    3. 5.3 Appendix | |
      1. 5.3.1 References | |
      2. 5.3.2 Related Reports 6 LIST OF FIGURES |
    4. 6.1 MARKET SYNOPSIS |
    5. 6.2 NORTH AMERICA MARKET ANALYSIS |
    6. 6.3 US MARKET ANALYSIS BY TYPE |
    7. 6.4 US MARKET ANALYSIS BY RODENT TYPE |
    8. 6.5 US MARKET ANALYSIS BY FORM |
    9. 6.6 US MARKET ANALYSIS BY END USER |
    10. 6.7 CANADA MARKET ANALYSIS BY TYPE |
    11. 6.8 CANADA MARKET ANALYSIS BY RODENT TYPE |
    12. 6.9 CANADA MARKET ANALYSIS BY FORM |
    13. 6.10 CANADA MARKET ANALYSIS BY END USER |
    14. 6.11 EUROPE MARKET ANALYSIS |
    15. 6.12 GERMANY MARKET ANALYSIS BY TYPE |
    16. 6.13 GERMANY MARKET ANALYSIS BY RODENT TYPE |
    17. 6.14 GERMANY MARKET ANALYSIS BY FORM |
    18. 6.15 GERMANY MARKET ANALYSIS BY END USER |
    19. 6.16 UK MARKET ANALYSIS BY TYPE |
    20. 6.17 UK MARKET ANALYSIS BY RODENT TYPE |
    21. 6.18 UK MARKET ANALYSIS BY FORM |
    22. 6.19 UK MARKET ANALYSIS BY END USER |
    23. 6.20 FRANCE MARKET ANALYSIS BY TYPE |
    24. 6.21 FRANCE MARKET ANALYSIS BY RODENT TYPE |
    25. 6.22 FRANCE MARKET ANALYSIS BY FORM |
    26. 6.23 FRANCE MARKET ANALYSIS BY END USER |
    27. 6.24 RUSSIA MARKET ANALYSIS BY TYPE |
    28. 6.25 RUSSIA MARKET ANALYSIS BY RODENT TYPE |
    29. 6.26 RUSSIA MARKET ANALYSIS BY FORM |
    30. 6.27 RUSSIA MARKET ANALYSIS BY END USER |
    31. 6.28 ITALY MARKET ANALYSIS BY TYPE |
    32. 6.29 ITALY MARKET ANALYSIS BY RODENT TYPE |
    33. 6.30 ITALY MARKET ANALYSIS BY FORM |
    34. 6.31 ITALY MARKET ANALYSIS BY END USER |
    35. 6.32 SPAIN MARKET ANALYSIS BY TYPE |
    36. 6.33 SPAIN MARKET ANALYSIS BY RODENT TYPE |
    37. 6.34 SPAIN MARKET ANALYSIS BY FORM |
    38. 6.35 SPAIN MARKET ANALYSIS BY END USER |
    39. 6.36 REST OF EUROPE MARKET ANALYSIS BY TYPE |
    40. 6.37 REST OF EUROPE MARKET ANALYSIS BY RODENT TYPE |
    41. 6.38 REST OF EUROPE MARKET ANALYSIS BY FORM |
    42. 6.39 REST OF EUROPE MARKET ANALYSIS BY END USER |
    43. 6.40 APAC MARKET ANALYSIS |
    44. 6.41 CHINA MARKET ANALYSIS BY TYPE |
    45. 6.42 CHINA MARKET ANALYSIS BY RODENT TYPE |
    46. 6.43 CHINA MARKET ANALYSIS BY FORM |
    47. 6.44 CHINA MARKET ANALYSIS BY END USER |
    48. 6.45 INDIA MARKET ANALYSIS BY TYPE |
    49. 6.46 INDIA MARKET ANALYSIS BY RODENT TYPE |
    50. 6.47 INDIA MARKET ANALYSIS BY FORM |
    51. 6.48 INDIA MARKET ANALYSIS BY END USER |
    52. 6.49 JAPAN MARKET ANALYSIS BY TYPE |
    53. 6.50 JAPAN MARKET ANALYSIS BY RODENT TYPE |
    54. 6.51 JAPAN MARKET ANALYSIS BY FORM |
    55. 6.52 JAPAN MARKET ANALYSIS BY END USER |
    56. 6.53 SOUTH KOREA MARKET ANALYSIS BY TYPE |
    57. 6.54 SOUTH KOREA MARKET ANALYSIS BY RODENT TYPE |
    58. 6.55 SOUTH KOREA MARKET ANALYSIS BY FORM |
    59. 6.56 SOUTH KOREA MARKET ANALYSIS BY END USER |
    60. 6.57 MALAYSIA MARKET ANALYSIS BY TYPE |
    61. 6.58 MALAYSIA MARKET ANALYSIS BY RODENT TYPE |
    62. 6.59 MALAYSIA MARKET ANALYSIS BY FORM |
    63. 6.60 MALAYSIA MARKET ANALYSIS BY END USER |
    64. 6.61 THAILAND MARKET ANALYSIS BY TYPE |
    65. 6.62 THAILAND MARKET ANALYSIS BY RODENT TYPE |
    66. 6.63 THAILAND MARKET ANALYSIS BY FORM |
    67. 6.64 THAILAND MARKET ANALYSIS BY END USER |
    68. 6.65 INDONESIA MARKET ANALYSIS BY TYPE |
    69. 6.66 INDONESIA MARKET ANALYSIS BY RODENT TYPE |
    70. 6.67 INDONESIA MARKET ANALYSIS BY FORM |
    71. 6.68 INDONESIA MARKET ANALYSIS BY END USER |
    72. 6.69 REST OF APAC MARKET ANALYSIS BY TYPE |
    73. 6.70 REST OF APAC MARKET ANALYSIS BY RODENT TYPE |
    74. 6.71 REST OF APAC MARKET ANALYSIS BY FORM |
    75. 6.72 REST OF APAC MARKET ANALYSIS BY END USER |
    76. 6.73 SOUTH AMERICA MARKET ANALYSIS |
    77. 6.74 BRAZIL MARKET ANALYSIS BY TYPE |
    78. 6.75 BRAZIL MARKET ANALYSIS BY RODENT TYPE |
    79. 6.76 BRAZIL MARKET ANALYSIS BY FORM |
    80. 6.77 BRAZIL MARKET ANALYSIS BY END USER |
    81. 6.78 MEXICO MARKET ANALYSIS BY TYPE |
    82. 6.79 MEXICO MARKET ANALYSIS BY RODENT TYPE |
    83. 6.80 MEXICO MARKET ANALYSIS BY FORM |
    84. 6.81 MEXICO MARKET ANALYSIS BY END USER |
    85. 6.82 ARGENTINA MARKET ANALYSIS BY TYPE |
    86. 6.83 ARGENTINA MARKET ANALYSIS BY RODENT TYPE |
    87. 6.84 ARGENTINA MARKET ANALYSIS BY FORM |
    88. 6.85 ARGENTINA MARKET ANALYSIS BY END USER |
    89. 6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY TYPE |
    90. 6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY RODENT TYPE |
    91. 6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY FORM |
    92. 6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USER |
    93. 6.90 MEA MARKET ANALYSIS |
    94. 6.91 GCC COUNTRIES MARKET ANALYSIS BY TYPE |
    95. 6.92 GCC COUNTRIES MARKET ANALYSIS BY RODENT TYPE |
    96. 6.93 GCC COUNTRIES MARKET ANALYSIS BY FORM |
    97. 6.94 GCC COUNTRIES MARKET ANALYSIS BY END USER |
    98. 6.95 SOUTH AFRICA MARKET ANALYSIS BY TYPE |
    99. 6.96 SOUTH AFRICA MARKET ANALYSIS BY RODENT TYPE |
    100. 6.97 SOUTH AFRICA MARKET ANALYSIS BY FORM |
    101. 6.98 SOUTH AFRICA MARKET ANALYSIS BY END USER |
    102. 6.99 REST OF MEA MARKET ANALYSIS BY TYPE |
    103. 6.100 REST OF MEA MARKET ANALYSIS BY RODENT TYPE |
    104. 6.101 REST OF MEA MARKET ANALYSIS BY FORM |
    105. 6.102 REST OF MEA MARKET ANALYSIS BY END USER |
    106. 6.103 KEY BUYING CRITERIA OF LIFE SCIENCES |
    107. 6.104 RESEARCH PROCESS OF MRFR |
    108. 6.105 DRO ANALYSIS OF LIFE SCIENCES |
    109. 6.106 DRIVERS IMPACT ANALYSIS: LIFE SCIENCES |
    110. 6.107 RESTRAINTS IMPACT ANALYSIS: LIFE SCIENCES |
    111. 6.108 SUPPLY / VALUE CHAIN: LIFE SCIENCES |
    112. 6.109 LIFE SCIENCES, BY TYPE, 2024 (% SHARE) |
    113. 6.110 LIFE SCIENCES, BY TYPE, 2024 TO 2035 (USD Billion) |
    114. 6.111 LIFE SCIENCES, BY RODENT TYPE, 2024 (% SHARE) |
    115. 6.112 LIFE SCIENCES, BY RODENT TYPE, 2024 TO 2035 (USD Billion) |
    116. 6.113 LIFE SCIENCES, BY FORM, 2024 (% SHARE) |
    117. 6.114 LIFE SCIENCES, BY FORM, 2024 TO 2035 (USD Billion) |
    118. 6.115 LIFE SCIENCES, BY END USER, 2024 (% SHARE) |
    119. 6.116 LIFE SCIENCES, BY END USER, 2024 TO 2035 (USD Billion) |
    120. 6.117 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
    121. 7.1 LIST OF ASSUMPTIONS | |
      1. 7.1.1 |
    122. 7.2 North America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.2.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.2.2 BY RODENT TYPE, 2025-2035 (USD Billion) | |
      3. 7.2.3 BY FORM, 2025-2035 (USD Billion) | |
      4. 7.2.4 BY END USER, 2025-2035 (USD Billion) |
    123. 7.3 US MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.3.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.3.2 BY RODENT TYPE, 2025-2035 (USD Billion) | |
      3. 7.3.3 BY FORM, 2025-2035 (USD Billion) | |
      4. 7.3.4 BY END USER, 2025-2035 (USD Billion) |
    124. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.4.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.4.2 BY RODENT TYPE, 2025-2035 (USD Billion) | |
      3. 7.4.3 BY FORM, 2025-2035 (USD Billion) | |
      4. 7.4.4 BY END USER, 2025-2035 (USD Billion) |
    125. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.5.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.5.2 BY RODENT TYPE, 2025-2035 (USD Billion) | |
      3. 7.5.3 BY FORM, 2025-2035 (USD Billion) | |
      4. 7.5.4 BY END USER, 2025-2035 (USD Billion) |
    126. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.6.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.6.2 BY RODENT TYPE, 2025-2035 (USD Billion) | |
      3. 7.6.3 BY FORM, 2025-2035 (USD Billion) | |
      4. 7.6.4 BY END USER, 2025-2035 (USD Billion) |
    127. 7.7 UK MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.7.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.7.2 BY RODENT TYPE, 2025-2035 (USD Billion) | |
      3. 7.7.3 BY FORM, 2025-2035 (USD Billion) | |
      4. 7.7.4 BY END USER, 2025-2035 (USD Billion) |
    128. 7.8 France MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.8.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.8.2 BY RODENT TYPE, 2025-2035 (USD Billion) | |
      3. 7.8.3 BY FORM, 2025-2035 (USD Billion) | |
      4. 7.8.4 BY END USER, 2025-2035 (USD Billion) |
    129. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.9.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.9.2 BY RODENT TYPE, 2025-2035 (USD Billion) | |
      3. 7.9.3 BY FORM, 2025-2035 (USD Billion) | |
      4. 7.9.4 BY END USER, 2025-2035 (USD Billion) |
    130. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.10.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.10.2 BY RODENT TYPE, 2025-2035 (USD Billion) | |
      3. 7.10.3 BY FORM, 2025-2035 (USD Billion) | |
      4. 7.10.4 BY END USER, 2025-2035 (USD Billion) |
    131. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.11.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.11.2 BY RODENT TYPE, 2025-2035 (USD Billion) | |
      3. 7.11.3 BY FORM, 2025-2035 (USD Billion) | |
      4. 7.11.4 BY END USER, 2025-2035 (USD Billion) |
    132. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.12.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.12.2 BY RODENT TYPE, 2025-2035 (USD Billion) | |
      3. 7.12.3 BY FORM, 2025-2035 (USD Billion) | |
      4. 7.12.4 BY END USER, 2025-2035 (USD Billion) |
    133. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.13.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.13.2 BY RODENT TYPE, 2025-2035 (USD Billion) | |
      3. 7.13.3 BY FORM, 2025-2035 (USD Billion) | |
      4. 7.13.4 BY END USER, 2025-2035 (USD Billion) |
    134. 7.14 China MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.14.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.14.2 BY RODENT TYPE, 2025-2035 (USD Billion) | |
      3. 7.14.3 BY FORM, 2025-2035 (USD Billion) | |
      4. 7.14.4 BY END USER, 2025-2035 (USD Billion) |
    135. 7.15 India MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.15.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.15.2 BY RODENT TYPE, 2025-2035 (USD Billion) | |
      3. 7.15.3 BY FORM, 2025-2035 (USD Billion) | |
      4. 7.15.4 BY END USER, 2025-2035 (USD Billion) |
    136. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.16.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.16.2 BY RODENT TYPE, 2025-2035 (USD Billion) | |
      3. 7.16.3 BY FORM, 2025-2035 (USD Billion) | |
      4. 7.16.4 BY END USER, 2025-2035 (USD Billion) |
    137. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.17.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.17.2 BY RODENT TYPE, 2025-2035 (USD Billion) | |
      3. 7.17.3 BY FORM, 2025-2035 (USD Billion) | |
      4. 7.17.4 BY END USER, 2025-2035 (USD Billion) |
    138. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.18.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.18.2 BY RODENT TYPE, 2025-2035 (USD Billion) | |
      3. 7.18.3 BY FORM, 2025-2035 (USD Billion) | |
      4. 7.18.4 BY END USER, 2025-2035 (USD Billion) |
    139. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.19.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.19.2 BY RODENT TYPE, 2025-2035 (USD Billion) | |
      3. 7.19.3 BY FORM, 2025-2035 (USD Billion) | |
      4. 7.19.4 BY END USER, 2025-2035 (USD Billion) |
    140. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.20.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.20.2 BY RODENT TYPE, 2025-2035 (USD Billion) | |
      3. 7.20.3 BY FORM, 2025-2035 (USD Billion) | |
      4. 7.20.4 BY END USER, 2025-2035 (USD Billion) |
    141. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.21.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.21.2 BY RODENT TYPE, 2025-2035 (USD Billion) | |
      3. 7.21.3 BY FORM, 2025-2035 (USD Billion) | |
      4. 7.21.4 BY END USER, 2025-2035 (USD Billion) |
    142. 7.22 South America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.22.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.22.2 BY RODENT TYPE, 2025-2035 (USD Billion) | |
      3. 7.22.3 BY FORM, 2025-2035 (USD Billion) | |
      4. 7.22.4 BY END USER, 2025-2035 (USD Billion) |
    143. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.23.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.23.2 BY RODENT TYPE, 2025-2035 (USD Billion) | |
      3. 7.23.3 BY FORM, 2025-2035 (USD Billion) | |
      4. 7.23.4 BY END USER, 2025-2035 (USD Billion) |
    144. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.24.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.24.2 BY RODENT TYPE, 2025-2035 (USD Billion) | |
      3. 7.24.3 BY FORM, 2025-2035 (USD Billion) | |
      4. 7.24.4 BY END USER, 2025-2035 (USD Billion) |
    145. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.25.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.25.2 BY RODENT TYPE, 2025-2035 (USD Billion) | |
      3. 7.25.3 BY FORM, 2025-2035 (USD Billion) | |
      4. 7.25.4 BY END USER, 2025-2035 (USD Billion) |
    146. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.26.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.26.2 BY RODENT TYPE, 2025-2035 (USD Billion) | |
      3. 7.26.3 BY FORM, 2025-2035 (USD Billion) | |
      4. 7.26.4 BY END USER, 2025-2035 (USD Billion) |
    147. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.27.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.27.2 BY RODENT TYPE, 2025-2035 (USD Billion) | |
      3. 7.27.3 BY FORM, 2025-2035 (USD Billion) | |
      4. 7.27.4 BY END USER, 2025-2035 (USD Billion) |
    148. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.28.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.28.2 BY RODENT TYPE, 2025-2035 (USD Billion) | |
      3. 7.28.3 BY FORM, 2025-2035 (USD Billion) | |
      4. 7.28.4 BY END USER, 2025-2035 (USD Billion) |
    149. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.29.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.29.2 BY RODENT TYPE, 2025-2035 (USD Billion) | |
      3. 7.29.3 BY FORM, 2025-2035 (USD Billion) | |
      4. 7.29.4 BY END USER, 2025-2035 (USD Billion) |
    150. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.30.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.30.2 BY RODENT TYPE, 2025-2035 (USD Billion) | |
      3. 7.30.3 BY FORM, 2025-2035 (USD Billion) | |
      4. 7.30.4 BY END USER, 2025-2035 (USD Billion) |
    151. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
      1. 7.31.1 |
    152. 7.32 ACQUISITION/PARTNERSHIP | |

Life Sciences Market Segmentation

Life Sciences By Type (USD Billion, 2025-2035)

  • Non-anticoagulant
  • Anticoagulant

Life Sciences By Rodent Type (USD Billion, 2025-2035)

  • Rat
  • Mouse
  • Hamsters
  • Chipmunk
  • Squirrels
  • Others

Life Sciences By Form (USD Billion, 2025-2035)

  • Pellet
  • Spray
  • Powder

Life Sciences By End User (USD Billion, 2025-2035)

  • Agricultural Fields
  • Warehouses
  • Others

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions